The Food and Drug Administration on Friday approved Eli Lilly’s weight-loss drug Zepbound to treat sleep apnea, a common but ...
The US Food and Drug Administration has approved Zepbound (tirzepatide) as the first prescription medication for the treatment of obstructive sleep apnea (OSA).
Zacks.com on MSN17h
Pharma Stock Roundup: NVO's Obesity Study Failure, FDA Nod to PFE, LLYNovo Nordisk NVO announced disappointing data from a phase III study on a novel obesity candidate. The FDA approved Eli Lilly ...
Men are underrepresented in health research, particularly lifestyle change trials. This study explores why, revealing ...
The Waverley Council says it will consider taking actions after tens of thousands of people trashed Sydney's Bronte Beach following a massive Christmas party. Tens of thousands of people have ...
Taxi jumps curb, slams into Christmas Day crowd outside Manhattan Macy’s on W. 34th St. A taxi cab jumped the curb and slammed into six pedestrians walking near Macy's on W. 34th St. and Sixth ...
The main opposition Democratic Party (DP) submitted an impeachment motion against acting President Han Duck-soo and reported it to a parliamentary plenary session Thursday. The ... The ...
The United States Food and Drug Administration (FDA) has approved the weight-loss drug Tirzepatide — sold by the brand name ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback